Category: Technology Licenses
Created On: 2022-04-28
Record Count: 8
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 3938
IPSCIO Record ID: 6202
Our AMPLATZER occlusion devices utilize our expertise in braiding nitinol, a metal alloy with superelastic and shape-memory characteristics, and designing transcatheter delivery systems.
IPSCIO Record ID: 5941
The Licensee has an exclusive worldwide License from the Licensor under United States patents entitled Occluder and Method for Repair of Cardiac and Vascular Defects (U.S. Patent No. 5,425,744), Occluder for Repair of Cardiac and Vascular Defects (U.S. Patent No. 5,451,235) and Self-Centering Umbrella-Type Septal Closure Device (U.S. Patent No. 5,709,707) and the respective corresponding foreign patents, patent applications and associated know-how.
IPSCIO Record ID: 29104
IPSCIO Record ID: 2991
IPSCIO Record ID: 6158
Patent ductus arteriosus (PDA) is a congenital disorder in the heart wherein a neonate's ductus arteriosus fails to close after birth.
IPSCIO Record ID: 3489
And MaXcess instruments provide access to the spine in a manner that affords direct visualization and our nerve monitoring systems assist surgeons in avoiding critical nerves. Our MaXcess system consists of instrumentation and specialized implants that provide maximum access to the spine with minimal soft tissue disruption. MaXcess has a split blade design consisting of three blades that can be positioned to build the surgical exposure in the shape and size specific to the surgical requirements rather than the fixed tube design of other minimally invasive surgical systems. MaXcessâ€™ split blade design also provides expanded access to the spine, which allows surgeons to perform surgical procedures using instruments that are similar to those used in open procedures but with a significantly smaller incision. The ability to use familiar instruments reduces the learning curve and facilitates the adoption of our products. Our systemâ€™s illumination of the operative corridor aids in providing surgeons with direct visualization of the patientâ€™s anatomy, without the need for additional technology or other special equipment.
IPSCIO Record ID: 336324
Per the Patent Sublicense Agreement,, Licensor hereby grants to Licensee a personal, nonexclusive sublicense under the Sublicensed Patent to make, have made for its own account, use, and import Licensed Products, and to sell, lease, offer for sale and otherwise transfer Licensed Products as hereinafter provided. Licensee or an Affiliate of Licensee may sell or transfer Licensed Products directly to End Users. Licensee or, in the event that Licensee first sells or transfers Licensed Products to any Affiliate of Licensee, such Affiliate, may also sell or transfer Licensed Products to Distributors for resale to End Users; provided, however, that any such Distributor must resell the Licensed Products to End Users in unchanged form, and provided further, that there shall be no more than one distribution channel for Licensed Products (i.e., one of Licensee or an affiliate of Licensee or a Distributor) in any specific country in the world. This sublicense specifically excludes any right of Licensee (or any Affiliate or Distributor of Licensee) to sell or otherwise transfer Licensed Products to OEM Customers.
United States Patent No. 6,436,135 – Prosthetic vascular graft
Field of Use shall mean the field of endovascular products i.e., medical products that are placed within the arteries or veins of the human body. The Field of Use expressly excludes any surgical prosthetic device intended in whole or in part to replace any portion of any artery, vein or other vessel or conduit within the human body, including but not limited to bypass grafts, dialysis grafts, aortic grafts or thoracic grafts.